6505--This is an intent to Sole Source. Gallium Ga-68 Dotate (Netspot)

The VA Central California Health Care System (VACCHCS) Palo Alto intends to negotiate a sole source contract with Advanced Accelerator Applications, Inc. The proposed contract action is for Gallium GA 68 Dotatate (NETSPOT) injections. The Gallium GA 68 Dotatate is proprietary, from the manufacturer Advanced Accelerator Applications, Inc. (see below for description and quantity needed).

This sole source action is in accordance with FAR 13.106-1. Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. THIS IS NOT A REQUEST FOR COMPETITIVE QUOTES and no competitive solicitation will be issued; however, any firm that believes it can meet this name brand only requirement, may give written notification to the contract specialist for consideration. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the requirements listed above for the requested name brand product. You must either be the manufacturer and/or an authorized distributor. Authorized distributors must provide documentation from the manufacturer on the manufacture s letter head.

Responses are due by January 19, 2021 at 9:00 AM PST. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

Responses must be e-mailed to katherine.fairley@va.gov. No telephone responses will be accepted. No reimbursement for any costs associated with providing capability statements will be provided by the Government.

Description/Part Number*

Gallium Ga-68 Dotatate (Netspot) Injection used to image diagnostically gastroenteropancreatic neuroendocrine tumors.

57 Each